{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:39:58Z","timestamp":1784785198600,"version":"3.55.0"},"reference-count":19,"publisher":"Royal College of General Practitioners","issue":"746","license":[{"start":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T00:00:00Z","timestamp":1549929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Gen Pract"],"accepted":{"date-parts":[[2024,1,29]]},"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Menopausal hormone therapy (MHT) can alleviate menopausal symptoms but has been associated with an increased risk of breast cancer. MHT prescription should be preceded by individualised risk\/benefit evaluation; however, data outlining the impact of family history alongside different MHT therapeutic approaches are lacking.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To quantify the risks associated with MHT use in women with varying breast cancer family histories of developing and dying from breast cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design and setting<\/jats:title><jats:p>An epidemiological modelling study for women in England using the BOADICEA breast cancer prediction model and data relating to MHT use and breast cancer risk taken from research by the Collaborative Group on Hormonal Factors in Breast Cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>The risk of developing and dying from breast cancer between the ages of 50 and 80 years was modelled in women with four different breast cancer family history profiles: \u2018average\u2019, \u2018modest\u2019, \u2018intermediate\u2019, and \u2018strong\u2019 by using 1) background risks of breast cancer by age and family history, 2) relative risks for breast cancer associated with MHT use, and 3) 10-year breast cancer-specific net mortality rates. This study modelled use of combined oestrogen-progestogen MHT (cyclical or continuous) and oestrogen-only MHT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>For a woman of \u2018average\u2019 family history taking no MHT, the cumulative breast cancer risk (age 50\u201380 years) is 9.8%, and the risk of dying from the breast cancer is 1.7%. In this model, 5 years\u2019 exposure to combined-cyclical MHT (age 50\u201355 years) was calculated to increase these risks to 11.0% and 1.8%, respectively. For a woman with a \u2018strong\u2019 family history taking no MHT, the cumulative breast cancer risk is 19.6% (age 50\u201380 years), and the risk of dying from the breast cancer is 3.2%. With 5 years\u2019 exposure to MHT (age 50\u201355 years), this model showed that these risks increase to 22.4% and 3.5%, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In this model, both family history and MHT are associated with increased risk of breast cancer. Estimates of the risks of breast cancer associated with MHT for women with different family histories can be used to support decision making around MHT prescription for women experiencing menopausal symptoms.<\/jats:p><\/jats:sec>","DOI":"10.3399\/bjgp.2023.0327","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T12:25:10Z","timestamp":1715257510000},"page":"e610-e618","source":"Crossref","is-referenced-by-count":9,"title":["Breast cancer risk assessment for prescription of menopausal hormone therapy in women with a family history of breast cancer: an epidemiological modelling study"],"prefix":"10.3399","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3797-7398","authenticated-orcid":false,"given":"Catherine","family":"Huntley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3487-9749","authenticated-orcid":false,"given":"Bethany","family":"Torr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9421-6667","authenticated-orcid":false,"given":"Grace","family":"Kavanaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3303-8713","authenticated-orcid":false,"given":"Helen","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1739-7986","authenticated-orcid":false,"given":"Katie","family":"Snape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Broggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Glasgow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7880-0628","authenticated-orcid":false,"given":"Marc","family":"Tischkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8482-5784","authenticated-orcid":false,"given":"D Gareth","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9223-3116","authenticated-orcid":false,"given":"Antonis C","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Turnbull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1987","published-online":{"date-parts":[[2024,5,9]]},"reference":[{"issue":"10204","key":"2025012103400794000_74.746.e610.1","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(19)32033-1","article-title":"Menopausal hormone therapy and 20-year breast cancer mortality","volume":"394","author":"Beral","year":"2019","journal-title":"Lancet"},{"key":"2025012103400794000_74.746.e610.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.3.321"},{"key":"2025012103400794000_74.746.e610.3","unstructured":"National Institute for Health and Care Excellence (2015) Menopause: diagnosis and management NG23 (NICE, London) https:\/\/www.nice.org.uk\/guidance\/ng23 (accessed 1 Jul 2024)."},{"key":"2025012103400794000_74.746.e610.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06524-2"},{"key":"2025012103400794000_74.746.e610.5","unstructured":"European Medicines Agency (2005) Guideline on clinical investigation of medicinal products for hormone replacement therapy of oestrogen deficiency symptoms in postmenopausal women, https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-clinical-investigation-medicinal-products-hormone-replacement-therapy-oestrogen-deficiency_en.pdf (accessed 21 Jun 2024)."},{"key":"2025012103400794000_74.746.e610.6","unstructured":"US Food and Drug Administration (2019) Menopause: from the FDA Office of Women\u2019s Health, https:\/\/www.fda.gov\/consumers\/womens-health-topics\/menopause (accessed 21 Jun 2024)."},{"key":"2025012103400794000_74.746.e610.7","doi-asserted-by":"publisher","DOI":"10.1136\/jmg-2022-108806"},{"key":"2025012103400794000_74.746.e610.8","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2022-108471"},{"key":"2025012103400794000_74.746.e610.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-018-0406-9"},{"key":"2025012103400794000_74.746.e610.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31709-X"},{"key":"2025012103400794000_74.746.e610.11","unstructured":"National Cancer Registration and Analysis Service (2018) https:\/\/www.cancerdata.nhs.uk\/ (accessed 27 Jun 2024)."},{"key":"2025012103400794000_74.746.e610.12","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-018-4782-2"},{"key":"2025012103400794000_74.746.e610.13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3873"},{"key":"2025012103400794000_74.746.e610.14","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-021-01399-7"},{"key":"2025012103400794000_74.746.e610.15","unstructured":"National Institute for Health and Care Excellence (2013) Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer CG164 (NICE, London) https:\/\/www.nice.org.uk\/guidance\/cg164 (accessed 1 Jul 2024)."},{"key":"2025012103400794000_74.746.e610.16","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.632"},{"key":"2025012103400794000_74.746.e610.17","unstructured":"Antoniou A (2023) CanRisk: online tool for calculation of future risk of developing breast and ovarian cancer. https:\/\/www.canrisk.org\/ (accessed 28 Jun 2024)."},{"key":"2025012103400794000_74.746.e610.18","unstructured":"Cuzick J (2017) IBIS (Tyrer Cuzick) Breast Cancer Risk Evaluation Tool. https:\/\/ibis.ikonopedia.com\/ (accessed 28 Jun 2024)."},{"key":"2025012103400794000_74.746.e610.19","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1668"}],"container-title":["British Journal of General Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3399\/BJGP.2023.0327","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T11:42:37Z","timestamp":1737459757000},"score":1,"resource":{"primary":{"URL":"http:\/\/bjgp.org\/lookup\/doi\/10.3399\/BJGP.2023.0327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,9]]},"references-count":19,"journal-issue":{"issue":"746","published-online":{"date-parts":[[2024,8,29]]},"published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.3399\/BJGP.2023.0327"],"URL":"https:\/\/doi.org\/10.3399\/bjgp.2023.0327","relation":{},"ISSN":["0960-1643","1478-5242"],"issn-type":[{"value":"0960-1643","type":"print"},{"value":"1478-5242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,9]]}}}